Tang Capital Management’s La Jolla Pharmaceutical Company LJPC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-9,607,934
| Closed | -$30.6M | – | 100 |
|
|
2022
Q2 | $30.6M | Hold |
9,607,934
| – | – | 4.65% | 6 |
|
|
2022
Q1 | $41M | Hold |
9,607,934
| – | – | 8.21% | 3 |
|
|
2021
Q4 | $44.7M | Sell |
9,607,934
-441,290
| -4% | -$1.84M | 8.99% | 4 |
|
|
2021
Q3 | $40.1M | Hold |
10,049,224
| – | – | 8.32% | 5 |
|
|
2021
Q2 | $43M | Buy |
10,049,224
+643,734
| +7% | +$2.76M | 8.56% | 5 |
|
|
2021
Q1 | $39.9M | Hold |
9,405,490
| – | – | 11.22% | 5 |
|
|
2020
Q4 | $36.5M | Hold |
9,405,490
| – | – | 5.57% | 5 |
|
|
2020
Q3 | $37.9M | Buy |
9,405,490
+710,016
| +8% | +$2.94M | 6.86% | 6 |
|
|
2020
Q2 | $37M | Buy |
8,695,474
+615,129
| +8% | +$3.75M | 3.6% | 6 |
|
|
2020
Q1 | $33.9M | Buy |
8,080,345
+3,141,452
| +64% | +$19.8M | 4.77% | 5 |
|
|
2019
Q4 | $19.4M | Hold |
4,938,893
| – | – | 2.32% | 8 |
|
|
2019
Q3 | $43.5M | Hold |
4,938,893
| – | – | 7.44% | 3 |
|
|
2019
Q2 | $45.7M | Hold |
4,938,893
| – | – | 6.17% | 3 |
|
|
2019
Q1 | $31.8M | Buy |
4,938,893
+1,060,000
| +27% | +$6.9M | 5.85% | 4 |
|
|
2018
Q4 | $36.6M | Sell |
3,878,893
-260,000
| -6% | -$3.91M | 8.39% | 4 |
|
|
2018
Q3 | $83.3M | Hold |
4,138,893
| – | – | 13.6% | 3 |
|
|
2018
Q2 | $121M | Hold |
4,138,893
| – | – | 15.3% | 3 |
|
|
2018
Q1 | $123M | Buy |
4,138,893
+698,474
| +20% | +$22.5M | 18.11% | 3 |
|
|
2017
Q4 | $111M | Hold |
3,440,419
| – | – | 17.54% | 3 |
|
|
2017
Q3 | $120M | Hold |
3,440,419
| – | – | 36.54% | 2 |
|
|
2017
Q2 | $102M | Hold |
3,440,419
| – | – | 36.35% | 2 |
|
|
2017
Q1 | $103M | Buy |
3,440,419
+249,254
| +8% | +$6.36M | 37.12% | 2 |
|
|
2016
Q4 | $55.9M | Hold |
3,191,165
| – | – | 29.83% | 2 |
|
|
2016
Q3 | $75.9M | Buy |
3,191,165
+139,035
| +5% | +$2.62M | 31.49% | 2 |
|
|
2016
Q2 | $48.8M | Hold |
3,052,130
| – | – | 21.76% | 2 |
|
|
2016
Q1 | $63.8M | Buy |
3,052,130
+180,000
| +6% | +$3.21M | 29.06% | 2 |
|
|
2015
Q4 | $77.5M | Sell |
2,872,130
-42,840
| -1% | -$1.17M | 30.77% | 2 |
|
|
2015
Q3 | $81M | Buy |
2,914,970
+250,000
| +9% | +$7.88M | 29.87% | 2 |
|
|
2015
Q2 | $65.3M | Buy |
2,664,970
+520,583
| +24% | +$10.7M | 19.82% | 2 |
|
|
2015
Q1 | $39.2M | Hold |
2,144,387
| – | – | 20.87% | 2 |
|
|
2014
Q4 | $39.6M | Buy |
2,144,387
+232,925
| +12% | +$2.76M | 21.69% | 2 |
|
|
2014
Q3 | $18.4M | Buy |
1,911,462
+1,029,555
| +117% | +$10.2M | 9.52% | 5 |
|
|
2014
Q2 | $8.1M | Buy |
881,907
+870,688
| +7,761% | +$7.95M | 3.75% | 7 |
|
|
2014
Q1 | $121K | Buy |
+11,219
| New | +$110K | 0.06% | 11 |
|
Tang Capital Management's LJPC Position: Q3 2022 in Review
Tang Capital Management sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2022, closing a stake of 9,607,934 shares — an estimated $30.6M sold.
Tang Capital Management first reported a position in LJPC in Q1 2014 and held it in 34 quarters. The position peaked at $123M in Q1 2018. 0 funds tracked by Wall St. Rank hold LJPC as of Q3 2022.
- Tang Capital Management reported no remaining La Jolla Pharmaceutical Company position as of Q3 2022 after selling out during the quarter.
- Tang Capital Management sold 9,607,934 La Jolla Pharmaceutical Company shares in Q3 2022, an estimated $30.6M.
- Tang Capital Management first reported a position in La Jolla Pharmaceutical Company in Q1 2014 and held it in 34 quarters.
- Tang Capital Management's La Jolla Pharmaceutical Company position peaked at $123M in Q1 2018.
- 0 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2022.
Based on Tang Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.